Edition:
United Kingdom

Bio Rad Laboratories Inc (BIO.N)

BIO.N on New York Stock Exchange

254.54USD
19 Jan 2018
Change (% chg)

$2.04 (+0.81%)
Prev Close
$252.50
Open
$252.90
Day's High
$255.73
Day's Low
$252.55
Volume
15,940
Avg. Vol
39,563
52-wk High
$272.88
52-wk Low
$183.64

Chart for

About

Bio-Rad Laboratories, Inc. (Bio-Rad) is a manufacturer and distributor of its life science research and clinical diagnostics products. The Company operates through two segments: Life Science and Clinical Diagnostics. It manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a... (more)

Overall

Beta: 0.89
Market Cap(Mil.): $6,701.81
Shares Outstanding(Mil.): 29.58
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 32.28 16.58
EPS (TTM): -- -- --
ROI: -- 13.90 10.60
ROE: -- 16.71 14.19

BRIEF-Bio-Rad Authorizes New $250 Million Share Repurchase Program

* BIO-RAD AUTHORIZES NEW $250 MILLION SHARE REPURCHASE PROGRAM

28 Nov 2017

BRIEF-Bio Rad Laboratories reports Q3 earnings per share $0.91

* Bio Rad Laboratories Inc reports third-quarter 2017 financial results

02 Nov 2017

BRIEF-U.S. ITC to probe certain 10X Genomics devices after Bio-Rad complaint

* U.S. U.S. International Trade Commission says it will investigate certain microfluidic devices by 10x Genomics Inc after complaint by Bio-rad Laboratories Inc and Lawrence Livermore National Security LLC. Source text for Eikon: Further company coverage: (Reporting By Susan Heavey)

31 Aug 2017

BRIEF-Bio-Rad reports Q2 earnings per share $0.17

* Q2 earnings per share view $0.56 -- Thomson Reuters I/B/E/S

03 Aug 2017

Earnings vs. Estimates